Translating knowledge

IOCBTech is a technology transfer office and subsidiary company of IOCB (the Institute of Organic Chemistry and Biochemistry CAS). The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.

Oxytocin

OXYTOCINTM

1958
Remestyp

TERLIPRESINTM

1965
Dermazulen

DERMAZULENTM

1969
Minirin

DESMOPRESINTM

1970
Usal

USALTM

1975
Adiuretin

ADIURETINTM

1975
Duvira gel

DUVIRA GELTM

1980
Duratocin

DURATOCINTM

1985
Vistide

VISTIDETM

1996

VIREADTM

2001

HEPSERATM

2002

TRUVADATM

2004

ATRIPLATM

2006

COMPLERATM

2011

STRIBILDTM

2012

Projects & Opportunities

Here you can explore our projects which are available for co-development or licensings.

About IOCB Tech

The IOCB Tech team supports management and decision-making processes in Target Research Groups of IOCB e.g. by due diligence analyses, market potential studies, and project feasibility evaluation. Moreover, the company is responsible for networking and industry partner search or negotiations of contracts and agreements in the field of intellectual property.

An integral part of IOCB Tech’s duties is the organization and development of spin-off companies on IOCB’s technology platform.

IOCB Team

News

05/28
2018

Winter school in DRUG DISCOVERY – Prague-Weizmann Winter School

05/28/2018
5th year of the Prague Summer School now Prague-Weizmann Winter School ADVANCES IN DRUG DISCOVERY NOVEL APPROACHES IN DRUG DESIGN AND DEVELOPMENT Rehovot, Israel, Dec 3rd – Dec 7th 2018   Following four successful years of the Prague Summer School on Advances in Drug Discovery, this year the…
05/28
2018

IOCB Tech at BioInternational in Boston

05/28/2018
IOCB Tech will be at the 25th anniversary of BioInternational in Boston. We are part of the BioMedChemCluster and can be found at Booth 1908a. Please take a look at the BioInternational event here.    …

Where to meet us?